News

Varenicline helps smokers with stably treated depression

View on the News

Trial may be helpful in understanding of non-psychiatrically ill smokers with history of depression

Dr. Vera DePalo

Dr. Vera DePalo, FCCP, comments: Smoking is a habit that contributes to several disease states and many strategies are employed to help with smoking cessation. Practitioners continue to search for the intervention that can aid the patient in success. As with all pharmacologic therapies,the prescriber considers the unintended side effects.
This industry-funded trial may be helpful to the practitioner's understanding of the possible options in non-psychiatrically ill smokers with a history of depression.


 

FROM ANNALS OF INTERNAL MEDICINE

*CORRECTION, 10/10/13: An earlier version of this article misstated the citation for the journal article referenced in the story.

Pages

Recommended Reading

Identify Depressive Symptoms Early in Breast Cancer Patients
MDedge Hematology and Oncology
Cancer Diagnosis Appears to Raise Suicide, Cardiovascular Risks
MDedge Hematology and Oncology
Hispanic Cancer Patients Suffer More Pain, Severe Sadness
MDedge Hematology and Oncology
Treat Comorbid Depression in Breast Cancer Patients
MDedge Hematology and Oncology
Depression May Shorten Survival in Kidney Cancer
MDedge Hematology and Oncology
Grief -- The Long and the Short of It
MDedge Hematology and Oncology
Snapshot after diagnosis: prevalence of distress varies by cancer, gender, and age
MDedge Hematology and Oncology
Job stress not linked with cancer risk
MDedge Hematology and Oncology
Harness side effects when selecting psychotropics for cancer patients
MDedge Hematology and Oncology
Escitalopram during cancer treatment reduces depression risk
MDedge Hematology and Oncology